Tenecteplase is used primarily to reduce mortality associated with which of the following clinical problems?
a- Diabetes
b- Myocardial infarction***
c- Hemorrhage
d- Prostate cancer
e- None of the above.
a- Diabetes
b- Myocardial infarction***
c- Hemorrhage
d- Prostate cancer
e- None of the above.
Labels
Pharma